nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2B6—Tamoxifen—pancreatic cancer	0.0912	0.108	CbGbCtD
Primidone—CYP2B6—Irinotecan—pancreatic cancer	0.0701	0.0832	CbGbCtD
Primidone—CYP2C8—Tamoxifen—pancreatic cancer	0.0691	0.082	CbGbCtD
Primidone—CYP1A2—Dacarbazine—pancreatic cancer	0.0672	0.0798	CbGbCtD
Primidone—CYP2C8—Erlotinib—pancreatic cancer	0.0588	0.0698	CbGbCtD
Primidone—CYP2C19—Tamoxifen—pancreatic cancer	0.058	0.0688	CbGbCtD
Primidone—CYP1A2—Tamoxifen—pancreatic cancer	0.0535	0.0635	CbGbCtD
Primidone—CYP2C8—Fluorouracil—pancreatic cancer	0.0509	0.0605	CbGbCtD
Primidone—CYP2C9—Tamoxifen—pancreatic cancer	0.0482	0.0572	CbGbCtD
Primidone—CYP1A2—Erlotinib—pancreatic cancer	0.0455	0.054	CbGbCtD
Primidone—CYP1A2—Fluorouracil—pancreatic cancer	0.0394	0.0468	CbGbCtD
Primidone—CYP2B6—Doxorubicin—pancreatic cancer	0.0383	0.0454	CbGbCtD
Primidone—CYP2C9—Fluorouracil—pancreatic cancer	0.0355	0.0422	CbGbCtD
Primidone—CYP3A4—Tamoxifen—pancreatic cancer	0.028	0.0333	CbGbCtD
Primidone—CYP3A4—Erlotinib—pancreatic cancer	0.0238	0.0283	CbGbCtD
Primidone—CYP3A4—Irinotecan—pancreatic cancer	0.0215	0.0255	CbGbCtD
Primidone—CYP3A4—Docetaxel—pancreatic cancer	0.0158	0.0187	CbGbCtD
Primidone—CYP3A4—Sunitinib—pancreatic cancer	0.0157	0.0186	CbGbCtD
Primidone—CYP3A4—Doxorubicin—pancreatic cancer	0.0118	0.014	CbGbCtD
Primidone—Eruption—Gemcitabine—pancreatic cancer	0.00354	0.0225	CcSEcCtD
Primidone—Blood disorder—Sunitinib—pancreatic cancer	0.00325	0.0206	CcSEcCtD
Primidone—Nystagmus—Fluorouracil—pancreatic cancer	0.003	0.019	CcSEcCtD
Primidone—Systemic lupus erythematosus—Docetaxel—pancreatic cancer	0.00279	0.0177	CcSEcCtD
Primidone—Eruption—Docetaxel—pancreatic cancer	0.00251	0.0159	CcSEcCtD
Primidone—Visual disturbance—Tamoxifen—pancreatic cancer	0.00243	0.0154	CcSEcCtD
Primidone—Depression—Tamoxifen—pancreatic cancer	0.00177	0.0112	CcSEcCtD
Primidone—Depression—Erlotinib—pancreatic cancer	0.00175	0.0111	CcSEcCtD
Primidone—Visual disturbance—Irinotecan—pancreatic cancer	0.00171	0.0109	CcSEcCtD
Primidone—Eruption—Epirubicin—pancreatic cancer	0.00169	0.0107	CcSEcCtD
Primidone—Eruption—Doxorubicin—pancreatic cancer	0.00157	0.00995	CcSEcCtD
Primidone—Connective tissue disorder—Erlotinib—pancreatic cancer	0.00155	0.00981	CcSEcCtD
Primidone—Visual impairment—Tamoxifen—pancreatic cancer	0.00153	0.00973	CcSEcCtD
Primidone—Depression—Sunitinib—pancreatic cancer	0.00151	0.0096	CcSEcCtD
Primidone—Eye disorder—Erlotinib—pancreatic cancer	0.00147	0.00933	CcSEcCtD
Primidone—Ataxia—Fluorouracil—pancreatic cancer	0.00146	0.00927	CcSEcCtD
Primidone—Nystagmus—Epirubicin—pancreatic cancer	0.00146	0.00926	CcSEcCtD
Primidone—Mental disorder—Erlotinib—pancreatic cancer	0.00138	0.00875	CcSEcCtD
Primidone—Malnutrition—Erlotinib—pancreatic cancer	0.00137	0.00869	CcSEcCtD
Primidone—Nystagmus—Doxorubicin—pancreatic cancer	0.00135	0.00856	CcSEcCtD
Primidone—Connective tissue disorder—Sunitinib—pancreatic cancer	0.00134	0.00849	CcSEcCtD
Primidone—Anaemia—Tamoxifen—pancreatic cancer	0.00128	0.00812	CcSEcCtD
Primidone—Eye disorder—Sunitinib—pancreatic cancer	0.00127	0.00808	CcSEcCtD
Primidone—Blood disorder—Epirubicin—pancreatic cancer	0.00125	0.00792	CcSEcCtD
Primidone—Mental disorder—Sunitinib—pancreatic cancer	0.00119	0.00757	CcSEcCtD
Primidone—Malnutrition—Sunitinib—pancreatic cancer	0.00119	0.00753	CcSEcCtD
Primidone—Visual disturbance—Docetaxel—pancreatic cancer	0.00118	0.00751	CcSEcCtD
Primidone—Arthralgia—Tamoxifen—pancreatic cancer	0.00118	0.00748	CcSEcCtD
Primidone—Arthralgia—Erlotinib—pancreatic cancer	0.00117	0.0074	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00116	0.00735	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—pancreatic cancer	0.00115	0.00732	CcSEcCtD
Primidone—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00114	0.00721	CcSEcCtD
Primidone—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00112	0.00709	CcSEcCtD
Primidone—Connective tissue disorder—Irinotecan—pancreatic cancer	0.0011	0.007	CcSEcCtD
Primidone—Nervous system disorder—Erlotinib—pancreatic cancer	0.0011	0.00696	CcSEcCtD
Primidone—Anaemia—Sunitinib—pancreatic cancer	0.0011	0.00696	CcSEcCtD
Primidone—Skin disorder—Erlotinib—pancreatic cancer	0.00109	0.00689	CcSEcCtD
Primidone—Visual impairment—Irinotecan—pancreatic cancer	0.00108	0.00686	CcSEcCtD
Primidone—Anorexia—Tamoxifen—pancreatic cancer	0.00108	0.00684	CcSEcCtD
Primidone—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00107	0.00682	CcSEcCtD
Primidone—Anorexia—Erlotinib—pancreatic cancer	0.00107	0.00676	CcSEcCtD
Primidone—Ataxia—Docetaxel—pancreatic cancer	0.00105	0.00669	CcSEcCtD
Primidone—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00103	0.00653	CcSEcCtD
Primidone—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00102	0.00646	CcSEcCtD
Primidone—Arthralgia—Sunitinib—pancreatic cancer	0.00101	0.00641	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.001	0.00636	CcSEcCtD
Primidone—Decreased appetite—Tamoxifen—pancreatic cancer	0.000982	0.00623	CcSEcCtD
Primidone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000976	0.00619	CcSEcCtD
Primidone—Fatigue—Tamoxifen—pancreatic cancer	0.000974	0.00618	CcSEcCtD
Primidone—Decreased appetite—Erlotinib—pancreatic cancer	0.000972	0.00617	CcSEcCtD
Primidone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000965	0.00613	CcSEcCtD
Primidone—Fatigue—Erlotinib—pancreatic cancer	0.000964	0.00612	CcSEcCtD
Primidone—Nervous system disorder—Sunitinib—pancreatic cancer	0.000949	0.00602	CcSEcCtD
Primidone—Skin disorder—Sunitinib—pancreatic cancer	0.00094	0.00597	CcSEcCtD
Primidone—Anorexia—Sunitinib—pancreatic cancer	0.000923	0.00585	CcSEcCtD
Primidone—Anaemia—Irinotecan—pancreatic cancer	0.000903	0.00573	CcSEcCtD
Primidone—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000882	0.0056	CcSEcCtD
Primidone—Anaemia—Gemcitabine—pancreatic cancer	0.000879	0.00558	CcSEcCtD
Primidone—Vertigo—Irinotecan—pancreatic cancer	0.000878	0.00557	CcSEcCtD
Primidone—Anaemia—Fluorouracil—pancreatic cancer	0.000865	0.00549	CcSEcCtD
Primidone—Decreased appetite—Sunitinib—pancreatic cancer	0.000841	0.00534	CcSEcCtD
Primidone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000836	0.0053	CcSEcCtD
Primidone—Fatigue—Sunitinib—pancreatic cancer	0.000834	0.0053	CcSEcCtD
Primidone—Asthenia—Tamoxifen—pancreatic cancer	0.000811	0.00514	CcSEcCtD
Primidone—Arthralgia—Gemcitabine—pancreatic cancer	0.00081	0.00514	CcSEcCtD
Primidone—Agranulocytosis—Docetaxel—pancreatic cancer	0.000806	0.00512	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000804	0.00511	CcSEcCtD
Primidone—Asthenia—Erlotinib—pancreatic cancer	0.000802	0.00509	CcSEcCtD
Primidone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000782	0.00496	CcSEcCtD
Primidone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000762	0.00484	CcSEcCtD
Primidone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000762	0.00483	CcSEcCtD
Primidone—Anorexia—Irinotecan—pancreatic cancer	0.00076	0.00482	CcSEcCtD
Primidone—Diplopia—Epirubicin—pancreatic cancer	0.000756	0.0048	CcSEcCtD
Primidone—Skin disorder—Gemcitabine—pancreatic cancer	0.000754	0.00479	CcSEcCtD
Primidone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000749	0.00475	CcSEcCtD
Primidone—Visual impairment—Docetaxel—pancreatic cancer	0.000748	0.00474	CcSEcCtD
Primidone—Dizziness—Tamoxifen—pancreatic cancer	0.000747	0.00474	CcSEcCtD
Primidone—Anorexia—Gemcitabine—pancreatic cancer	0.00074	0.0047	CcSEcCtD
Primidone—Dizziness—Erlotinib—pancreatic cancer	0.000739	0.00469	CcSEcCtD
Primidone—Anorexia—Fluorouracil—pancreatic cancer	0.000728	0.00462	CcSEcCtD
Primidone—Eye disorder—Docetaxel—pancreatic cancer	0.000725	0.0046	CcSEcCtD
Primidone—Vomiting—Tamoxifen—pancreatic cancer	0.000718	0.00456	CcSEcCtD
Primidone—Rash—Tamoxifen—pancreatic cancer	0.000712	0.00452	CcSEcCtD
Primidone—Dermatitis—Tamoxifen—pancreatic cancer	0.000712	0.00452	CcSEcCtD
Primidone—Ataxia—Epirubicin—pancreatic cancer	0.000711	0.00451	CcSEcCtD
Primidone—Vomiting—Erlotinib—pancreatic cancer	0.000711	0.00451	CcSEcCtD
Primidone—Somnolence—Irinotecan—pancreatic cancer	0.000709	0.0045	CcSEcCtD
Primidone—Headache—Tamoxifen—pancreatic cancer	0.000708	0.00449	CcSEcCtD
Primidone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000708	0.00449	CcSEcCtD
Primidone—Rash—Erlotinib—pancreatic cancer	0.000705	0.00447	CcSEcCtD
Primidone—Dermatitis—Erlotinib—pancreatic cancer	0.000704	0.00447	CcSEcCtD
Primidone—Headache—Erlotinib—pancreatic cancer	0.0007	0.00444	CcSEcCtD
Primidone—Diplopia—Doxorubicin—pancreatic cancer	0.0007	0.00444	CcSEcCtD
Primidone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000696	0.00441	CcSEcCtD
Primidone—Asthenia—Sunitinib—pancreatic cancer	0.000694	0.00441	CcSEcCtD
Primidone—Decreased appetite—Irinotecan—pancreatic cancer	0.000693	0.0044	CcSEcCtD
Primidone—Somnolence—Gemcitabine—pancreatic cancer	0.00069	0.00438	CcSEcCtD
Primidone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000688	0.00437	CcSEcCtD
Primidone—Fatigue—Irinotecan—pancreatic cancer	0.000687	0.00436	CcSEcCtD
Primidone—Mental disorder—Docetaxel—pancreatic cancer	0.00068	0.00431	CcSEcCtD
Primidone—Somnolence—Fluorouracil—pancreatic cancer	0.000679	0.00431	CcSEcCtD
Primidone—Malnutrition—Docetaxel—pancreatic cancer	0.000675	0.00429	CcSEcCtD
Primidone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000675	0.00428	CcSEcCtD
Primidone—Nausea—Tamoxifen—pancreatic cancer	0.000671	0.00426	CcSEcCtD
Primidone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00067	0.00425	CcSEcCtD
Primidone—Fatigue—Gemcitabine—pancreatic cancer	0.00067	0.00425	CcSEcCtD
Primidone—Nausea—Erlotinib—pancreatic cancer	0.000664	0.00421	CcSEcCtD
Primidone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000664	0.00421	CcSEcCtD
Primidone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000659	0.00418	CcSEcCtD
Primidone—Ataxia—Doxorubicin—pancreatic cancer	0.000658	0.00418	CcSEcCtD
Primidone—Dizziness—Sunitinib—pancreatic cancer	0.00064	0.00406	CcSEcCtD
Primidone—Anaemia—Docetaxel—pancreatic cancer	0.000624	0.00396	CcSEcCtD
Primidone—Vomiting—Sunitinib—pancreatic cancer	0.000615	0.0039	CcSEcCtD
Primidone—Rash—Sunitinib—pancreatic cancer	0.00061	0.00387	CcSEcCtD
Primidone—Dermatitis—Sunitinib—pancreatic cancer	0.00061	0.00387	CcSEcCtD
Primidone—Headache—Sunitinib—pancreatic cancer	0.000606	0.00385	CcSEcCtD
Primidone—Drowsiness—Epirubicin—pancreatic cancer	0.000583	0.0037	CcSEcCtD
Primidone—Arthralgia—Docetaxel—pancreatic cancer	0.000575	0.00365	CcSEcCtD
Primidone—Nausea—Sunitinib—pancreatic cancer	0.000575	0.00365	CcSEcCtD
Primidone—Asthenia—Irinotecan—pancreatic cancer	0.000572	0.00363	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000571	0.00362	CcSEcCtD
Primidone—Asthenia—Gemcitabine—pancreatic cancer	0.000557	0.00354	CcSEcCtD
Primidone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000544	0.00345	CcSEcCtD
Primidone—Nervous system disorder—Docetaxel—pancreatic cancer	0.00054	0.00343	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—pancreatic cancer	0.000539	0.00342	CcSEcCtD
Primidone—Skin disorder—Docetaxel—pancreatic cancer	0.000535	0.0034	CcSEcCtD
Primidone—Dizziness—Irinotecan—pancreatic cancer	0.000527	0.00335	CcSEcCtD
Primidone—Anorexia—Docetaxel—pancreatic cancer	0.000525	0.00333	CcSEcCtD
Primidone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000514	0.00326	CcSEcCtD
Primidone—Vomiting—Irinotecan—pancreatic cancer	0.000507	0.00322	CcSEcCtD
Primidone—Dizziness—Fluorouracil—pancreatic cancer	0.000505	0.0032	CcSEcCtD
Primidone—Visual impairment—Epirubicin—pancreatic cancer	0.000504	0.0032	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000503	0.00319	CcSEcCtD
Primidone—Rash—Irinotecan—pancreatic cancer	0.000503	0.00319	CcSEcCtD
Primidone—Dermatitis—Irinotecan—pancreatic cancer	0.000502	0.00319	CcSEcCtD
Primidone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000502	0.00319	CcSEcCtD
Primidone—Headache—Irinotecan—pancreatic cancer	0.000499	0.00317	CcSEcCtD
Primidone—Vomiting—Gemcitabine—pancreatic cancer	0.000494	0.00313	CcSEcCtD
Primidone—Somnolence—Docetaxel—pancreatic cancer	0.00049	0.00311	CcSEcCtD
Primidone—Rash—Gemcitabine—pancreatic cancer	0.00049	0.00311	CcSEcCtD
Primidone—Dermatitis—Gemcitabine—pancreatic cancer	0.000489	0.0031	CcSEcCtD
Primidone—Eye disorder—Epirubicin—pancreatic cancer	0.000489	0.0031	CcSEcCtD
Primidone—Headache—Gemcitabine—pancreatic cancer	0.000486	0.00309	CcSEcCtD
Primidone—Vomiting—Fluorouracil—pancreatic cancer	0.000485	0.00308	CcSEcCtD
Primidone—Rash—Fluorouracil—pancreatic cancer	0.000481	0.00306	CcSEcCtD
Primidone—Dermatitis—Fluorouracil—pancreatic cancer	0.000481	0.00305	CcSEcCtD
Primidone—Decreased appetite—Docetaxel—pancreatic cancer	0.000479	0.00304	CcSEcCtD
Primidone—Headache—Fluorouracil—pancreatic cancer	0.000478	0.00304	CcSEcCtD
Primidone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000476	0.00302	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000476	0.00302	CcSEcCtD
Primidone—Fatigue—Docetaxel—pancreatic cancer	0.000475	0.00302	CcSEcCtD
Primidone—Nausea—Irinotecan—pancreatic cancer	0.000474	0.00301	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—pancreatic cancer	0.000467	0.00296	CcSEcCtD
Primidone—Nausea—Gemcitabine—pancreatic cancer	0.000461	0.00293	CcSEcCtD
Primidone—Mental disorder—Epirubicin—pancreatic cancer	0.000458	0.00291	CcSEcCtD
Primidone—Malnutrition—Epirubicin—pancreatic cancer	0.000455	0.00289	CcSEcCtD
Primidone—Nausea—Fluorouracil—pancreatic cancer	0.000454	0.00288	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—pancreatic cancer	0.000452	0.00287	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—pancreatic cancer	0.000424	0.00269	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—pancreatic cancer	0.000421	0.00267	CcSEcCtD
Primidone—Anaemia—Epirubicin—pancreatic cancer	0.000421	0.00267	CcSEcCtD
Primidone—Vertigo—Epirubicin—pancreatic cancer	0.000409	0.0026	CcSEcCtD
Primidone—Asthenia—Docetaxel—pancreatic cancer	0.000395	0.00251	CcSEcCtD
Primidone—Anaemia—Doxorubicin—pancreatic cancer	0.000389	0.00247	CcSEcCtD
Primidone—Arthralgia—Epirubicin—pancreatic cancer	0.000388	0.00246	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000385	0.00244	CcSEcCtD
Primidone—Vertigo—Doxorubicin—pancreatic cancer	0.000379	0.0024	CcSEcCtD
Primidone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000365	0.00231	CcSEcCtD
Primidone—Dizziness—Docetaxel—pancreatic cancer	0.000364	0.00231	CcSEcCtD
Primidone—Skin disorder—Epirubicin—pancreatic cancer	0.000361	0.00229	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—pancreatic cancer	0.000359	0.00228	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000356	0.00226	CcSEcCtD
Primidone—Anorexia—Epirubicin—pancreatic cancer	0.000354	0.00225	CcSEcCtD
Primidone—Vomiting—Docetaxel—pancreatic cancer	0.00035	0.00222	CcSEcCtD
Primidone—Rash—Docetaxel—pancreatic cancer	0.000347	0.00221	CcSEcCtD
Primidone—Dermatitis—Docetaxel—pancreatic cancer	0.000347	0.0022	CcSEcCtD
Primidone—Headache—Docetaxel—pancreatic cancer	0.000345	0.00219	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000339	0.00215	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000337	0.00214	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—pancreatic cancer	0.000334	0.00212	CcSEcCtD
Primidone—Somnolence—Epirubicin—pancreatic cancer	0.00033	0.0021	CcSEcCtD
Primidone—Anorexia—Doxorubicin—pancreatic cancer	0.000328	0.00208	CcSEcCtD
Primidone—Nausea—Docetaxel—pancreatic cancer	0.000327	0.00208	CcSEcCtD
Primidone—Decreased appetite—Epirubicin—pancreatic cancer	0.000323	0.00205	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000321	0.00204	CcSEcCtD
Primidone—Fatigue—Epirubicin—pancreatic cancer	0.00032	0.00203	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000313	0.00199	CcSEcCtD
Primidone—Somnolence—Doxorubicin—pancreatic cancer	0.000306	0.00194	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000299	0.0019	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000297	0.00188	CcSEcCtD
Primidone—Fatigue—Doxorubicin—pancreatic cancer	0.000297	0.00188	CcSEcCtD
Primidone—Asthenia—Epirubicin—pancreatic cancer	0.000267	0.00169	CcSEcCtD
Primidone—Asthenia—Doxorubicin—pancreatic cancer	0.000247	0.00157	CcSEcCtD
Primidone—Dizziness—Epirubicin—pancreatic cancer	0.000246	0.00156	CcSEcCtD
Primidone—Vomiting—Epirubicin—pancreatic cancer	0.000236	0.0015	CcSEcCtD
Primidone—Rash—Epirubicin—pancreatic cancer	0.000234	0.00149	CcSEcCtD
Primidone—Dermatitis—Epirubicin—pancreatic cancer	0.000234	0.00149	CcSEcCtD
Primidone—Headache—Epirubicin—pancreatic cancer	0.000233	0.00148	CcSEcCtD
Primidone—Dizziness—Doxorubicin—pancreatic cancer	0.000227	0.00144	CcSEcCtD
Primidone—Nausea—Epirubicin—pancreatic cancer	0.000221	0.0014	CcSEcCtD
Primidone—Vomiting—Doxorubicin—pancreatic cancer	0.000219	0.00139	CcSEcCtD
Primidone—Rash—Doxorubicin—pancreatic cancer	0.000217	0.00138	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—pancreatic cancer	0.000217	0.00137	CcSEcCtD
Primidone—Headache—Doxorubicin—pancreatic cancer	0.000215	0.00137	CcSEcCtD
Primidone—Nausea—Doxorubicin—pancreatic cancer	0.000204	0.0013	CcSEcCtD
